Detecting the Deadliest Cancers at Early Stages with Blood Samples with Jo Bhakdi, Founder and CEO of Quantgene
Today, we are privileged to feature the outstanding Jo Bhakdi, Founder and CEO of Quantgene. Jo discusses how his company is building the most advanced genomics technology that can detect cancer and other diseases earlier, while they are easier to treat. He talks about the genesis of the Quantgene, the benefits of merging genomic sequencing with AI, Serenity System and it’s amazing ability to detect diseases, the challenges they faced, and many more.
Jo and his team are building the future of medicine, which is so exciting. Learn more about Quantgene and how it can impact healthcare in this podcast episode.
Click this link to the show notes, transcript, and resources: outcomesrocket.health
